New smart insulin pump aims for better blood sugar control

NCT ID NCT06865989

Completed Disease control Sponsor: Insulet Corporation Source: ClinicalTrials.gov ↗

Summary

This study tested a newer version of an automated insulin pump system (SmartAdjust 2.0) against the current version (Omnipod 5) in people with type 1 or type 2 diabetes. The goal was to see if the newer system is just as safe and effective at keeping blood sugar in a healthy range. Participants used each system for several weeks to compare their daily blood sugar control.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Show contact details

Locations

Baylor College of Medicine

Houston, Texas, 77030, United States
Diabetes and Glandular Disease Clinic

San Antonio, Texas, 78229, United States
Henry Ford

Detroit, Michigan, 48202, United States
International Diabetes Center

Minneapolis, Minnesota, 55416, United States
Joslin Diabetes Center

Boston, Massachusetts, 02215, United States
Northwestern University

Chicago, Illinois, 60611, United States
Sansum Diabetes Research Institute

Santa Barbara, California, 93105, United States
University Hospitals Cleveland

Cleveland, Ohio, 44106, United States
University of Colorado Denver

Aurora, Colorado, 80045, United States
University of Southern California

Los Angeles, California, 90022, United States
Yale University School of Medicine

New Haven, Connecticut, 06511, United States

Conditions

Explore the condition pages connected to this study.

DIABETES MELLITUS, TYPE 1, TYPE 2